Arvinas (ARVN) Debt Ratio (2017 - 2026)
Arvinas' (ARVN) quarterly Debt Ratio came in at 0.0 in Q1 2026, up 10.44% year-on-year from 0.0 in Q1 2025, and up 38.59% quarter-over-quarter from 0.0 in Q4 2025.
Arvinas (ARVN) Debt Ratio (2017 - 2026) Analysis & Trends
Arvinas' Debt Ratio history runs 10 years deep, the most recent figure standing at 0.0 for Q1 2026.
- On a quarterly basis, Debt Ratio rose 10.44% year-over-year to 0.0 in Q1 2026; TTM through Mar 2026 was 0.0, a 10.44% increase from a year earlier, with the FY2025 full-year figure at 0.0, down 23.99% from the prior year.
- Debt Ratio grew to 0.0 in Q1 2026 per ARVN's latest filing, from 0.0 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.0 in Q3 2023 and bottomed at 0.0 in Q3 2024.
- The 5-year median for Debt Ratio is 0.0 (2022), against an average of 0.0.
- Across the five-year window, Debt Ratio sank 77.1% in 2022 and jumped 51.35% in 2023, its largest moves.
- Year by year, Debt Ratio stood at 0.0 in 2022, then decreased by 22.2% to 0.0 in 2023, then climbed by 19.53% to 0.0 in 2024, then dropped by 23.99% to 0.0 in 2025, then jumped by 38.59% to 0.0 in 2026.
- Per Business Quant, the three latest ARVN Debt Ratio figures stand at 0.0 (Q1 2026), 0.0 (Q4 2025), and 0.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |